日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

免疫疗法改善了携带 Kirsten 大鼠肉瘤病毒突变的不可切除非小细胞肺癌 III 期患者的临床结果:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Ruznic, Elvis; Klebermass, Marisa; Zellinger, Barbara; Langer, Brigitte; Grambozov, Brane; Purevdorj, Ayurzana; Karner, Josef; Gruber, Georg; Stana, Markus; Minasch, Danijela; Kirchhammer, Karoline; Steffal, Claudia; Stranzl, Heidi; Moosbrugger, Raphaela; Feurstein, Petra; Dieckmann, Karin; Zehentmayr, Franz

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

删除SNX9可缓解CD8 T细胞耗竭,从而实现有效的细胞癌症免疫治疗。

Marcel P Trefny ,Nicole Kirchhammer ,Priska Auf der Maur ,Marina Natoli ,Dominic Schmid ,Markus Germann ,Laura Fernandez Rodriguez ,Petra Herzig ,Jonas Lötscher ,Maryam Akrami ,Jane C Stinchcombe ,Michal A Stanczak ,Andreas Zingg ,Melanie Buchi ,Julien Roux ,Romina Marone ,Leyla Don ,Didier Lardinois ,Mark Wiese ,Lukas T Jeker ,Mohamed Bentires-Alj ,Jérémie Rossy ,Daniela S Thommen ,Gillian M Griffiths ,Heinz Läubli ,Christoph Hess ,Alfred Zippelius

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

TLR9 和 PD-L1 双重靶向释放树突状细胞以诱导持久的抗肿瘤免疫力

Laura Fernandez-Rodriguez #, Chiara Cianciaruso #, Ruben Bill, Marcel P Trefny, Richard Klar, Nicole Kirchhammer, Mélanie Buchi, Julia Festag, Sven Michel, Rainer H Kohler, Elham Jones, Andre Maaske, Johannes Vom Berg, Sebastian Kobold, Abhishek S Kashyap, Frank Jaschinski, Karen O Dixon, Mikael J P

Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade

靶向癌症糖基化可使肿瘤相关巨噬细胞重新极化,从而实现有效的免疫检查点阻断

Michal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, David E Sanin, Francis Jacob, Ricardo Coelho, Arun V Everest-Dass, Jinyu Wang, Marcel P Trefny, Gianni Monaco, Anne Bärenwaldt, Melissa A Gray, Adam Petrone, Abhishek S Kashyap, Katharina Glatz, Benjamin Kasenda, Karl Normington, Jam

Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer

Siglec 受体调节癌症中的树突状细胞活化和向 T 细胞的抗原呈递

Jinyu Wang, Michela Manni, Anne Bärenwaldt, Ronja Wieboldt, Nicole Kirchhammer, Robert Ivanek, Michal Stanczak, Alfred Zippelius, David König, Natalia Rodrigues Manutano, Heinz Läubli

Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack

异源沙粒病毒载体启动-加强免疫可克服自身耐受性,从而有效攻击肿瘤特异性CD8 T细胞

Weldy V Bonilla ,Nicole Kirchhammer ,Anna-Friederike Marx ,Sandra M Kallert ,Magdalena A Krzyzaniak ,Min Lu ,Stéphanie Darbre ,Sarah Schmidt ,Josipa Raguz ,Ursula Berka ,Ilena Vincenti ,Mindaugas Pauzuolis ,Romy Kerber ,Sabine Hoepner ,Stephan Günther ,Carsten Magnus ,Doron Merkler ,Klaus K Orlinger ,Alfred Zippelius ,Daniel D Pinschewer

iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy

iMATCH:用于治疗组合高容量腺病毒基因治疗的集成模块化组装系统

Dominik Brücher, Nicole Kirchhammer, Sheena N Smith, Jatina Schumacher, Nina Schumacher, Jonas Kolibius, Patrick C Freitag, Markus Schmid, Fabian Weiss, Corina Keller, Melanie Grove, Urs F Greber, Alfred Zippelius, Andreas Plückthun

A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)

一种新型兔源抗 HER2 抗体,在体外和人源化肿瘤小鼠(HTM)中对 HER2 阳性乳腺癌细胞具有显著的治疗效果

Anja Kathrin Wege, Nicole Kirchhammer, Linda Veronique Kazandjian, Sandra Prassl, Michael Brandt, Gerhard Piendl, Olaf Ortmann, Stephan Fischer, Gero Brockhoff

GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses

微管不稳定时 GEF-H1 信号传导是树突状细胞活化和特异性抗肿瘤反应所必需的

Abhishek S Kashyap ,Laura Fernandez-Rodriguez ,Yun Zhao ,Gianni Monaco ,Marcel P Trefny ,Naohiro Yoshida ,Kea Martin ,Ashwani Sharma ,Natacha Olieric ,Pankaj Shah ,Michal Stanczak ,Nicole Kirchhammer ,Sung-Moo Park ,Sebastien Wieckowski ,Heinz Laubli ,Rachid Zagani ,Benjamin Kasenda ,Michel O Steinmetz ,Hans-Christian Reinecker ,Alfred Zippelius

Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice

体外乳腺癌细胞系以及免疫缺陷和人源化肿瘤小鼠中程序性死亡配体 1 (PD-L1) 表达的调节

Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, Olaf Ortmann, Anja K Wege, Gero Brockhoff